Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Pfizer presents P3 data at ASH next week December 9th
And Fabry deal discussions are well underway after getting Acellerated Approval from FDA recently. A couple of nice near term catalysts that should move the stock.
No comment yet